EUCTR2013-003911-23-FR进行中（未招募）1 期
Evaluation of cardiac uptake during a PET examination 18F Flutematamol (Vizamyl®) in cardiac damage amyloid.
CHU Toulouse0 个研究点目标入组 15 人开始时间: 2015年9月16日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- 未提供
研究者
相似试验
已完成
不适用
on-invasive estimation of cardiac output by plethysmographic signalJPRN-UMIN000010921Toho University Ohashi Medical Center, Department of Anesthesiology42
已完成
不适用
Whole-body organ uptake of PET tracer [18F]SMBT-1healthy volunteerJPRN-UMIN000041176Tohoku University Cyclotron and Radioisotope Center8
已完成
不适用
tility of non-invasive cardiac output measurements in adult hospital patients with low blood pressure during Medical Emergency Team review.hypotensionsepsisACTRN12617001336370Siddharth Goswami40
招募中
不适用
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID TrialLung CarcinomaEsophageal CarcinomaNCT05775939Thomas Jefferson University20
已完成
1 期
A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2MProstate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancerJPRN-UMIN000015356niversity of Tsukuba15